#AAPMR23

Dr. McLaughlin is a dually-trained pediatric physiatrist and clinical pharmacologist whose primary research encompasses the concepts of Precision Medicine and Pharmacogenomics. He utilizes the premise of trying to incorporate ‘the right drug at the right time in the right patient’ to optimize treatments related to spasticity and neuropathic pain in children with cerebral palsy. He currently serves as an associate professor and division director at Children’s Mercy in Kansas City, Missouri. In addition to an NIH-sponsored Clinical Pharmacology Fellowship, he has undertaken significant training from the Rehabilitation Medicine Scientist Training Program and the Neurorehabilitation and Restorative Neuroscience Training Networks. He has received both K- and R-level funding from the National Institute of Health/National Center for Medical Rehabilitation Research for his work in Precision Medicine. He has been the recipient of many awards, such as the Best Article by a Young Investigator in the PM&R Journal, the Presidential Trainee award and the Darrell Abernethy Award, both through the American Society of Clinical Pharmacology and Therapeutics.
Dr. McLaughlin’s passions outside of work involve cycling and adaptive sports, and he has merged these roles serving as both an international and national-level paracycling classifier for Union Cycliste Internacionale and the United States Olympic and Paralympic Committee. Through his volunteerism with AAPM&R, ABPMR and AAP, he has made many significant connections to the specialty.
Learn more about our 2023 AAPM&R Awards Winners: www.aapmr.org/about-aapm-r/vo...